✦ LIBER ✦

Benefits and Drawbacks of the Use of Oral Fluoropyrimidines as Single-Agent Therapy in Advanced Colorectal Cancer

✍ Scribed by Jim Cassidy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pemetrexed as a single agent in the ther

✍ Pieter E. Postmus; Paul A. Bunn Jr 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 83 KB

High-dose, single-agent irinotecan as fi

✍ M. Ychou; J. Raoul; F. Desseigne; C. Borel; F. Caroli-Bosc; J. Jacob; J. Seitz; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 279 KB

XELOX and bevacizumab followed by single

✍ Rosati, Gerardo; Avallone, Antonio; Aprile, Giuseppe; Butera, Alfredo; Reggiardo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 269 KB

Retrospective analysis of clinical resul

✍ Kan Yonemori; Yasuhiro Shimada; Ayumu Goto; Takashi Ura; Tatsuhiro Arai; Tetsuya 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 171 KB

Mitoxantrone (novantrone∗) as single age

✍ Smith, I.E.; Stuart-Harris, R.; Pavlidis, N.; Bozek, T. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 306 KB

A randomised phase III trial of the phar

✍ Middleton, Gary; Brown, Sarah; Lowe, Catherine; Maughan, Timothy; Gwyther, Steph 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 614 KB